Group 1 - Morgan Stanley raised the price target on East West Bancorp (EWBC) to $141 from $126, maintaining an Equal Weight rating on the shares [1] - The firm is increasing price targets by a median of 8% across the midcap banks group [1] - The firm remains optimistic on the group, citing tailwinds from loan growth, net interest margin, and capital return [1]

Bill Ready, CEO, Pinterest, speaks at the 28th annual Milken Institute Global Conference at the Beverly Hilton in Beverly Hills, California on May 5, 2025.Pinterest's stock jumped 8% after Elliott Investment Management made a $1 billion investment in the social media company.The company said it plans to use the investment to buy back stock as part of a $3.5 billion share repurchase program approved by the board."Elliott's investment is a strong vote of confidence in the work we have done to build our busine ...

Morgan Stanley analyst Manan Gosalia raised the firm’s price target on Fifth Third (FITB) to $67 from $60 and keeps an Overweight rating on the shares. The firm is increasing price targets by a median 8% across the midcap banks group. While noting that recent outperformance means “the bar is higher from here,” the firm remains optimistic on the group, citing tailwinds from loan growth, net interest margin and capital return. Published first on TheFly – the ultimate source for real-time, market-moving bre ...

Expedia (EXPE) Group announced a new partnership with PredictHQ. The company said the integration gives lodging partners a clearer view of rising travel demand by combining PredictHQ’s forward-looking demand forecasts with Expedia Group’s rich traveler insights, empowering them to identify, anticipate, and act on demand shifts with greater confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Re ...

Truist lowered the firm’s price target on Procept BioRobotics (PRCT) to $30 from $47 but keeps a Buy rating on the shares. The company’s Q4 missed estimates, though its Analyst Day laid out a case for sustainable growth of 25% or more through 2027, highlighted by ongoing penetration into the BPH opportunity, strategy changes geared towards increasing utilization and more visibility into the business, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real- ...

Morgan Stanley raised the firm’s price target on Flagstar Financial (FLG) to $16 from $14 and keeps an Equal Weight rating on the shares. The firm is increasing price targets by a median 8% across the midcap banks group. While noting that recent outperformance means “the bar is higher from here,” the firm remains optimistic on the group, citing tailwinds from loan growth, net interest margin and capital return. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia ...

Morgan Stanley analyst Manan Gosalia raised the firm’s price target on Huntington Bancshares (HBAN) to $23 from $21 and keeps an Overweight rating on the shares. The firm is increasing price targets by a median 8% across the midcap banks group. While noting that recent outperformance means “the bar is higher from here,” the firm remains optimistic on the group, citing tailwinds from loan growth, net interest margin and capital return. Published first on TheFly – the ultimate source for real-time, market- ...

Industry veteran to oversee global product development across banking and retail, focusing on new and emerging technologies NORTH CANTON, Ohio, March 3, 2026 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, today announced that Andy Zosel has joined the company as executive vice president, chief product and technology officer. In this newly created role, Zosel will lead the company's unified Product & Technology organization to bring together produc ...

The Collaboration Framework marks Adial’s first step towards commercial partnership and establishing an exclusive European pathway as AD04 advances toward pivotal Phase 3 developmentGLEN ALLEN, Va., March 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction and related disorders, today announced it has entered into a collaboration framework agreement with Molteni F ...

Horace Mann (HMN) approved a 3% increase in the quarterly cash dividend to 36c per share. This represents an indicated annual dividend of $1.44 per share payable on March 31 to shareholders of record as of March 17. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on HMN: Disclaimer & DisclosureReport an Issue ...